MedDataX Logo

Prospective Data Collection of Newly Diagnosed Hodgkin's Disease and Non-Hodgkin's Lymphoma Cases

NCT ID: NCT00538551

Last Updated: 2011-12-13

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

350 participants

Study Classification

OBSERVATIONAL

Study Start Date

2007-01-31

Study Completion Date

2015-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Prospective Data Collection of Newly Diagnosed Hodgkin's Disease and Non-Hodgkin's Lymphoma Cases

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Prospective Data Collection of Newly Diagnosed HD and NHL.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hodgkin Disease Lymphoma, Non-Hodgkin

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

HD NHL

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Database

Database

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Database of Newly Diagnosed HD and NHL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients with newly diagnosed Hodgkin's Disease and Non-Hodgkin's Lymphoma

Exclusion Criteria

* Patients with diagnosis other than HD and NHL.
Minimum Eligible Age

14 Years

Maximum Eligible Age

85 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

King Faisal Specialist Hospital & Research Center

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Syed Akhtar, MD

Role: PRINCIPAL_INVESTIGATOR

KFSH & RC

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

KFSH&RC

Riyadh, , Saudi Arabia

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Saudi Arabia

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Syed Akhtar, MD

Role: CONTACT

Phone: 966-1-4647272

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Syed Akhtar, MD

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

RAC#2021-048

Identifier Type: -

Identifier Source: secondary_id

RAC #2021-048

Identifier Type: -

Identifier Source: org_study_id